<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04047368</url>
  </required_header>
  <id_info>
    <org_study_id>ROTA.shock</org_study_id>
    <nct_id>NCT04047368</nct_id>
  </id_info>
  <brief_title>Comparison of Coronary Lithoplasty and Rotablation</brief_title>
  <official_title>Comparison of Coronary Lithoplasty and Rotablation for the Interventional Treatment of Severely Calcified Coronary Stenoses - ROTA.Shock-Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Else Kröner-Fresenius Stiftung, Bad Homburg, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares a new method of treating severely calcified coronary lesions, the
      intracoronary lithoplasty, with the current gold standard, the rotablation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Severe coronary calcification is still a challenge for percutaneous coronary intervention
      (PCI). Reduction of the calcified plaque mass is necessary to achieve adequate stent
      expansion during further course. Rotablation has been the only reliable option to treat
      extremely calcified coronary lesions for a long time. Coronary lithoplasty has been recently
      introduced as a new promising treatment option in this special subset. It provides the unique
      opportunity to break severely calcified plaque structures even inside deeper layers of the
      vessel wall. Aim of this study is to compare rotablation and coronary lithotripsy for
      treatment of severely calcified coronary lesions. Plaque structure, plaque volume, as well as
      lumen diameters will be analyzed by optical coherence tomography (OCT) before and after
      debulking, as well as after stent implantation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 28, 2019</start_date>
  <completion_date type="Anticipated">June 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimal Stent Area (End of the Procedure)</measure>
    <time_frame>0 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minimal/Mean/Maximal Stent Diameter</measure>
    <time_frame>0 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimal/Mean/Maximal Lumen area</measure>
    <time_frame>0 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimal/Mean/Maximal Lumen diameter</measure>
    <time_frame>0 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean/Maximal Stent area</measure>
    <time_frame>0 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of target lesion failure</measure>
    <time_frame>0 months; 1 month; 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of target vessel failure</measure>
    <time_frame>0 months; 1 month; 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE rate</measure>
    <time_frame>0 months; 1 month; 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Calcified Atheroma</condition>
  <arm_group>
    <arm_group_label>Rotablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Coronary Lithoplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rotablation</intervention_name>
    <description>Percutaneous Coronary Intervention using Rotablation</description>
    <arm_group_label>Rotablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary Lithoplasty</intervention_name>
    <description>Percutaneous Coronary Intervention using Lithoplasty</description>
    <arm_group_label>Coronary Lithoplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18 yrs

          -  Stable coronary heart disease or acute coronary syndromes

          -  Single or multi vessel disease. Vessel is defined as, left anterior descending, left
             circumflex, and right coronary arteries. Any branch within the vessel is considered
             part of the vessel.

          -  Written informed consent was obtained before the procedure

          -  Severely calcified coronary lesion with indication for rotablation

        Exclusion Criteria:

          -  Known renal insufficiency (serum creatinine clearance &lt;30ml/min/1.73m² or receiving
             dialysis)

          -  Known allergy against protocol-required medications including ASS, prasugrel,
             ticagrelor, clopidogrel, heparin. History of bleeding diathesis or known coagulopathy

          -  Cardiogenic shock

          -  Lesion length &gt; 32mm

          -  Bifurcation lesions requiring 2-Stent-Strategies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florian Blachutzik, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Giessen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florian Blachutzik, Dr.</last_name>
    <phone>+49 641 985 42212</phone>
    <email>florian.blachutzik@innere.med.uni-giessen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Giessen</name>
      <address>
        <city>Gießen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Blachutzik, Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>July 22, 2019</study_first_submitted>
  <study_first_submitted_qc>August 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2019</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Rotablation</keyword>
  <keyword>Coronary lithoplasty</keyword>
  <keyword>Optical coherence tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Plaque, Atherosclerotic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

